MDQK.HM MediNavi AG (HAM) up 200.00% 17 Mar 2026: liquidity and outlook

MDQK.HM stock soared to €7.50, a 200.00% intraday gain on 17 Mar 2026 during market hours on the HAM exchange in Germany. The surge started from an open of €2.50 with a day low of €2.50 and a day high of €7.50. Volume stayed low at 35.00 shares against an average of 41.00, so the move reflects large price volatility on thin liquidity. Below we break down financials, technicals, a Meyka grade, and a model forecast to frame risk and possible trade setups.

Price action and trading context for MDQK.HM stock

MDQK.HM stock moved from €2.50 to €7.50 on 17 Mar 2026, marking a €5.00 change and 200.00% increase. One claim per paragraph: this move occurred on 35.00 shares traded, so price volatility outpaced volume. The stock’s 50-day average is €2.50 and 200-day average is €2.00, showing the current price is above both moving averages but on very low turnover. Traders should note the year low is €1.50 and year high is €7.50, so the stock is trading at the annual peak on thin volume.

Fundamentals and ratios driving MDQK.HM stock analysis

MediNavi AG operates in Healthcare, Medical – Healthcare Information Services, listed on HAM in Germany and reports limited public financial metrics. EPS is N/A and P/E is N/A, so valuation ratios are unavailable. Balance-sheet metrics show a very high current ratio of 41.50, working capital of 269,922.60 EUR, and tangible asset value of 1,783,753.60 EUR, which suggests cash and asset buffers but minimal operating earnings. Enterprise value is negative at -255,031.00 EUR, and interest coverage is -1,362.59, indicating historical losses and unusual capital structure signals.

Technical setup and risk with low liquidity

Technicals show strong short-term breakout against the 50-day average (€2.50), but RSI and MACD data are not informative. ATR is 5.00, reflecting large intraday swings. Traders should treat the spike as liquidity-driven; low average volume (41.00) can amplify moves and widen bid-ask spreads. One claim per paragraph: stop levels and small position sizing are prudent when trading MDQK.HM stock because market depth is thin.

Meyka AI grade and model forecast for MDQK.HM stock

Meyka AI rates MDQK.HM with a score of 62.57 out of 100 — Grade B, Suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects a 12-month central target of €3.50, a conservative 3-month target of €4.50, and an optimistic 12-month scenario at €6.00. Compared with the current price €7.50, the central projection implies a downside of -53.33%; forecasts are model-based projections and not guarantees.

Catalysts, sector context and news flow for MDQK.HM stock

No formal earnings announcement or analyst upgrades were recorded before the move; company website activity shows ongoing platform operations. The Healthcare sector performance is softer year-to-date, with average sector P/E at 29.33, so MediNavi’s disconnected metrics stand out. Watch for regulatory updates, partnership news, or capital raises as likely catalysts that could validate a sustained price level for MediNavi AG. For company details see the official site and Meyka stock page source source.

Trade ideas, valuation and scenario planning for MDQK.HM stock

Short-term traders can target quick profits on intraday swings but must size positions for low liquidity. A stop-loss near €2.50 (the open and prior close) keeps risk defined. For investors, the lack of reported EPS and thin trading argues for caution; if MediNavi reports material positive revenue growth or a strategic contract, a revised valuation could lift targets. Consider risk scenarios: recovery to €6.00 on positive news, or reversion toward €3.50 if the move proves ephemeral.

Final Thoughts

Key takeaways on MDQK.HM stock: the share price jumped to €7.50 on 17 Mar 2026, a 200.00% swing from the prior close, but the move occurred on just 35.00 shares. That combination signals high volatility driven by low liquidity rather than confirmed fundamental improvement. Meyka AI rates MDQK.HM 62.57/100 (B, HOLD) after factoring benchmark and sector comparisons, financial growth, and key metrics. Meyka AI’s forecast model projects a 12-month central target of €3.50, implying -53.33% from today’s price; alternative scenarios place a short-term target at €4.50 and a bullish case at €6.00. These forecasts are model-based projections and not guarantees. Investors should wait for clear fundamental news, higher volume, or audited financial updates before assuming the current price level is sustainable. Follow risk controls and consider smaller position sizes given the very low average volume on HAM and limited public financial disclosures.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.